Stanley Bukofzer

Title: The Innovations of Stanley Bukofzer

Introduction

Stanley Bukofzer is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. His innovative work has led to the development of a unique formulation that offers alternative treatment options for patients suffering from hyperammonemia.

Latest Patents

Stanley Bukofzer holds a patent for "Formulations of L-ornithine phenylacetate." This patent focuses on oral formulations of L-ornithine phenylacetate and methods of using these formulations. The invention provides an alternative administration route compared to the standard intravenous method, which is particularly beneficial for treating hyperammonemia in patients with various acute and chronic liver diseases. These conditions include acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, and urea cycle disorders. He has 1 patent to his name.

Career Highlights

Stanley Bukofzer is associated with Ocera Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company has been instrumental in exploring new therapeutic avenues for patients with liver-related health issues.

Collaborations

Some of his notable coworkers include Laurene Wang and Linda S Grais. Their collaborative efforts contribute to the innovative environment at Ocera Therapeutics, Inc.

Conclusion

Stanley Bukofzer's contributions to the field of medicine through his patent on L-ornithine phenylacetate formulations highlight his commitment to improving patient care. His work exemplifies the impact of innovation in addressing complex health challenges.